News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,495 Results
Type
Article (16096)
Company Profile (73)
Press Release (280326)
Section
Business (95266)
Career Advice (848)
Deals (17912)
Drug Delivery (49)
Drug Development (36506)
Employer Resources (63)
FDA (8049)
Job Trends (6887)
News (158428)
Policy (14064)
Tag
Academia (1133)
Alliances (22301)
Alzheimer's disease (585)
Approvals (8053)
Artificial intelligence (100)
Bankruptcy (139)
Best Places to Work (5898)
Biotechnology (65)
Breast cancer (102)
Cancer (789)
Cardiovascular disease (53)
Career advice (702)
Cell therapy (161)
Clinical research (29303)
Collaboration (321)
Compensation (63)
COVID-19 (1272)
C-suite (63)
Data (847)
Diabetes (85)
Diagnostics (3134)
Earnings (44851)
Employer resources (59)
Events (35915)
Executive appointments (196)
FDA (8410)
Funding (264)
Gene therapy (111)
GLP-1 (282)
Government (1704)
Healthcare (9099)
Infectious disease (1330)
Inflammatory bowel disease (63)
Interviews (141)
IPO (9208)
Job creations (1291)
Job search strategy (594)
Layoffs (195)
Legal (3458)
Lung cancer (119)
Lymphoma (57)
Manufacturing (102)
Medical device (6051)
Medtech (6053)
Mergers & acquisitions (8858)
Metabolic disorders (237)
Neuroscience (769)
NextGen Class of 2024 (2578)
Non-profit (1847)
Northern California (962)
Obesity (141)
Opinion (122)
Patents (68)
People (23914)
Phase I (9502)
Phase II (12805)
Phase III (9795)
Pipeline (426)
Postmarket research (1038)
Preclinical (3747)
Radiopharmaceuticals (175)
Rare diseases (139)
Real estate (1880)
Regulatory (9566)
Research institute (1050)
Resumes & cover letters (154)
Southern California (766)
Startups (1551)
United States (7816)
Vaccines (312)
Weight loss (98)
Date
Today (5)
Last 7 days (97)
Last 30 days (1119)
Last 365 days (19259)
2024 (19246)
2023 (21630)
2022 (27917)
2021 (29998)
2020 (27149)
2019 (20842)
2018 (16110)
2017 (15651)
2016 (14052)
2015 (16430)
2014 (11596)
2013 (8922)
2012 (9469)
2011 (10099)
2010 (8994)
Location
Africa (349)
Asia (18589)
Australia (3098)
California (2055)
Canada (935)
China (167)
Colorado (80)
Connecticut (97)
Europe (42640)
Florida (272)
Georgia (68)
Illinois (175)
Indiana (87)
Japan (61)
Kansas (60)
Maryland (365)
Massachusetts (1557)
Michigan (119)
Minnesota (107)
New Jersey (653)
New York (579)
North Carolina (348)
Northern California (962)
Ohio (63)
Pennsylvania (441)
South America (491)
Southern California (766)
Texas (261)
Washington State (215)
296,495 Results for "genzyme general".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
Novartis Loses Appeal to Bar Entresto Generic From U.S. Market
Novartis is seeking to prevent the entry of generics for its blockbuster heart failure drug Entresto, its top-selling asset that brought in more than $6 billion in net global sales last year.
December 5, 2024
·
2 min read
·
Tristan Manalac
Legal
Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement
Sarepta has been hit with another patent infringement lawsuit, this time from Sanofi and its subsidiary Genzyme alleging that the biotech used protected technology related to AAV vectors.
August 1, 2024
·
2 min read
·
Tristan Manalac
Earnings
Teva Reports Strong Generics Demand in Q3, Expects Higher 2024 Revenue
Driven by copycat versions of Bristol Myers Squibb’s Revlimid and Novo Nordisk’s Victoza, Teva’s generics business was again a top-performer in the third quarter, with U.S. sales growing 30% and bringing in $1.1 billion in sales.
November 7, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Result of General Meeting
November 22, 2024
·
4 min read
Press Releases
Upstream Bio Appoints Allison Ambrose as General Counsel
December 17, 2024
·
5 min read
Job Trends
How Is Generative AI Transforming Clinical Trial Work?
Generative AI could enhance and accelerate the way people work on clinical trials. In this Q&A, a management consultant shares his insights on benefits, risks and more.
August 1, 2024
·
5 min read
·
Angela Gabriel
Deals
Flagship’s AI Company Generate Inks Deal Worth up to $1B With Novartis
Flagship Pioneering–backed Generate:Biomedicines has signed its second major Big Pharma partnership, bringing in $65 million upfront to use its AI platform to discover novel protein drug candidates.
September 24, 2024
·
2 min read
·
Annalee Armstrong
Patents
FDA Denies Novartis’ Petition to Block Entresto Generics
In addition to facing generic competition, Entresto is among the initial 10 drugs selected for the Inflation Reduction Act’s Medicare Drug Price Negotiation Program, with the maximum fair prices to be published by Sept. 1.
July 31, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Next Generation CD40 Targeted Cancer Therapies
December 5, 2024
·
1 min read
Genetown
Combined General Meeting of June 24, 2024
Biophytis SA will hold its Combined General Meeting on June 24, 2024 at 2pm at Sorbonne Université - Amphi Herpin - 4 Place Jussieu, 75005 Paris.
June 7, 2024
·
3 min read
1 of 29,650
Next
